Synthesis and NMR studies of 13C-labeled vitamin D metabolites

Journal of Organic Chemistry

Volumn 67, Issue 5, 2002, Pages 1637-1650

  Okamura, William H ^a   Zhu, Gui Dong ^a   Hill, David K ^a   Thomas, Richard J ^a   Ringe, Kerstin ^a   Borchardt, Daniel B ^a   Norman, Anthony W ^a   Mueller, Leonard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

BIOLOGICAL MEMBRANES; DRUG DOSAGE; HORMONES; ISOTOPES; KETONES; METABOLITES; MICELLES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PROTEINS; SYNTHESIS (CHEMICAL);

VITAMINS;

CALCIFEDIOL; CALCITRIOL; CARBON 13; COLECALCIFEROL; CYCLODEXTRIN DERIVATIVE; DODECYL SULFATE SODIUM; DRUG METABOLITE; METHYLMAGNESIUM IODIDE; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTOPE LABELING; MICELLE; NUCLEAR OVERHAUSER EFFECT; REACTION ANALYSIS; SOLID STATE; VITAMIN D METABOLISM; X RAY CRYSTALLOGRAPHY;

CARBON ISOTOPES; CATALYSIS; CHOLESTANES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLOGRAPHY, X-RAY; ISOTOPE LABELING; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXIDATION-REDUCTION; STEREOISOMERISM; VITAMIN D;

EID: 0037040656     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo011096y     Document Type: Article

References (75)

1. Structure-function relationships in the vitamin D endocrine system
2. Chemistry and design: Structural biology of vitamin D action
3. Synthesis of vitamin D (calciferol)
4. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
5. Large-scale expression and purification of the human vitamin D receptor. Its ligand-binding domain for structural studies
6. Ligand binding to the nuclear receptor for vitamin D
7. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands
8. Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor
9. Chemistry and conformation of vitamin D molecules
10. 3 based on the provitamin D skeleton
11. Vitamin D: Structure-function analyses and the design of analogs
12. Conformationally restricted mimics of vitamin D rotamers
13. 3
14. 3 monohydrate: A stereo-chemical analysis of vitamin D molecules
15. Crystal and molecular structure of 1,25-dihydroxycholecalciferol
16. 1
17. No. 280. Étude de la résonance magnétique nucléaire du précalciférol du tachystérol et du calciférol
18. 3
19. Elucidation of the solution conformation of the A ring in vitamin D using proton coupling constants and a shift reagent
20. 3 by high-resolution proton magnetic resonance spectroscopy
21. 1H nuclear magnetic resonance studies of the conformations of vitamin D compounds in various solvents
22. 3
23. 3: Synthesis and study of pentadeuterio derivatives
24. On the antarafacial stereochemistry of the thermal [1,7]-sigmatropic hydrogen shift
25. 3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses
26. 3: Analogs are able to functionally differentiate between nuclear and membrane receptors
27. 3 in basal lateral membranes of chick intestinal epithelium and relationship to transcaltachia
28. 3 which mediates rapid activation of protein kinase C
29. 3
30. 3 to Annexin II: Effect of vitamin D metabolites and calcium
31. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis nor 6-s-trans locked analogues are preferred for genomic biological responses
32. Use of a Double half-filter in two-dimensional proton NMR studies of receptor-bound cyclosporin
33. Proton-proton overhauser effects of receptor-bound cyclosporin A observed with the use of a heteronuclear-resolved half-filter experiment
34. Nuclear magnetic resonance studies demonstrate differences in the interaction of retinoic acid with two highly homologous cellular retinoic acid binding proteins
35. Binding of retinol induces changes in rat cellular retinol-binding protein II conformation and backbone dynamics
36. 13C]-β-ionones bound to β-lactoglobulin B
37. Determination of membrane protein structure by rotational resonance NMR: Bacteriorhodopsin
38. Dipolar correlation NMR spectroscopy of a membrane protein
39. 13C NMR analysis of the conformational equilibrium of the A-ring
40. 3
41. 3 analogs
42. The vitamin D-3,5-cyclovitamin D rearrangement
43. 3 metabolites. Control of the stereoselectivity in samarium-induced cyclopropanations of cyclopentenes
44. Control of stereoselectivity in samarium metal induced cyclopropanations. Synthesis of 1,25-dihydroxycholecalciferol
45. Intramolecular cyclopropanation using iodonium ylides. The 3,5-cyclovitamin D ring A synthon
46. A novel intramolecular cyclopropanation using iodonium ylides
47. 3 A-ring precursors
48. 6-ketocyclovitamin and its conversion to A ring B/C spirosteroid
49. 4 to 25-hydroxycholecaliferol and its 3,5-cyclo derivative
50. A synthetic method for the formyl to ethynyl conversion
51. 3 analogues: Stereoselective preparation of 6β-vitamin D vinylallenes and a concise enynol synthesis for preparing the A-ring
52. 3
53. "Anomalous" ozonolysis of cyclic allylic alcohols: Mechanism and synthetic utility
54. 14C label in enones
55. 3 to its 1,25-dihydroxy metabolite
56. 3
57. 3 Windaus-Grundmann ketone
58. 3 triepoxide and of its 25-hydroxy derivative
59. Oxidations by methyl(trifluoromethyl)dioxirane. Oxyfunctionalization of saturated hydrocarbons. 2
60. Self-association of cholesterol in aqueous solution
61. NMR studies of cyclodextrins and cyclodextrin complexes
62. Critical micelle concentrations of aqueous surfactant systems
63. Protein structure determination with three- and four-dimensional NMR spectroscopy
64. Assessment of errors involved in the determination of interproton distance ratios and distances by means of one- and two-dimensional NOE measurements
65. Binding of vitamin D to low-density-lipoprotein (LDL) and LDL receptor-mediated pathway into cells
66. Stereocontrolled total synthesis of 1α,25-dihydroxycholecalciferol and 1α,25-dihydroxyergocalciferol
67. 3